Conduit Pharmaceuticals Inc.(CDT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CDT Conduit Pharmaceuticals Inc.

Post-Market Trading 12-24 13:15:53 EST

0.0591

+0.0046

+8.44%

盘后0.0573

-0.0018-3.05%

13:15 EST

High0.0620	Low0.0532	Vol6.23M
Open0.0541	D1 Closing0.0545	Amplitude16.15%
Mkt Cap7.08M	Tradable Cap4.40M	Total Shares119.86M
T/O359.19K	T/O Rate8.38%	Tradable Shares74.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CDT","market":"US","secType":"STK","nameCN":"Conduit Pharmaceuticals Inc.","latestPrice":0.0591,"timestamp":1735063199999,"preClose":0.0545,"halted":0,"volume":6228531,"hourTrading":{"tag":"盘后","latestPrice":0.0573,"preClose":0.0591,"latestTime":"13:15 EST","volume":11771,"amount":679.1896074370001,"timestamp":1735064122230},"delay":0,"floatShares":74369457,"shares":119858640,"eps":-0.238984,"marketStatus":"Post-Market Trading","change":0.0046,"latestTime":"12-24 13:15:53 EST","open":0.0541,"high":0.062,"low":0.0532,"amount":359194.979198583,"amplitude":0.161468,"askPrice":0.0621,"askSize":200,"bidPrice":0.0572,"bidSize":40,"shortable":0,"etf":0,"ttmEps":-0.238984,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1735077600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0545,"preHourTrading":{"tag":"盘前","latestPrice":0.0554,"preClose":0.0545,"latestTime":"09:26 EST","volume":219551,"amount":12456.96806738,"timestamp":1735050388215},"postHourTrading":{"tag":"盘后","latestPrice":0.0573,"preClose":0.0591,"latestTime":"13:15 EST","volume":11771,"amount":679.1896074370001,"timestamp":1735064122230},"volumeRatio":0.622172},"requestUrl":"/m/hq/s/CDT","defaultTab":"news","newsList":[{"id":"2493754800","title":"Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2493754800","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493754800?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:42","pubTimestamp":1734957721,"startTime":"0","endTime":"0","summary":"Shares of Rumble Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42644814/why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139",".IXIC","BK4555","HMC","ATXS","ONFO","BK4099","USJW.SI","CLB","AILE","BK4082","KOD","NSANY","RELI","BK4007","TSYW.SI","TQQQ","TPIC","ABAT","EDBL","PHIO","BK4121","MNQmain","USAW.SI","PSQ","QLD","SQQQ","BK4173","BK4179","JDZG","RUM","QID","BK4096","APTO","SIGA","BK4585","BNRG","BK4583","BK4077","NQmain","BK4133","BK4141","CDT","NVIW.SI","CNTM","BK4023","HSDT","BK4505"],"gpt_icon":1},{"id":"2490480061","title":"BRIEF-Conduit Pharmaceuticals Partners With Sarborg To Leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2490480061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490480061?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:44","pubTimestamp":1734007469,"startTime":"0","endTime":"0","summary":"BRIEF-Conduit Pharmaceuticals Partners With Sarborg To LeverageDec 12 (Reuters) - Conduit Pharmaceuticals CDT.O:CONDUIT PHARMACEUTICALS TO REVOLUTIONIZE DRUG DEVELOPMENT THROUGH AGREEMENT TO USE ARTIF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2490807750","title":"Conduit Pharmaceuticals to enter agreement with SARBOR","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807750?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:35","pubTimestamp":1734006910,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals (CDT) announced that it has entered into an agreement with SARBOR to leverage an advanced artificial intelligence and cyber...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/conduit-pharmaceuticals-to-enter-agreement-with-sarbor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/conduit-pharmaceuticals-to-enter-agreement-with-sarbor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2490807654","title":"Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807654?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2490807131","title":"Conduit Pharmaceuticals Inc - Partners With Sarborg to Leverage AI and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807131?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2490005408","title":"Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490005408","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490005408?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and clinical trial monitoring.This innovative approach aims to reduce human error, cut costs, and improve efficiency, positioning Conduit for success across its current and future portfolio.By entering into this agreement with Sarborg, Conduit will address longstanding challenges in the pharmaceutical sector by seeking to reduce human error in critical decision-making processes including clinical development and asset identification. By integrating Sarborg’s algorithmic AI and cybernetics technology, Conduit aims to enhance efficiency, lower costs, and accelerate timelines by minimizing human intervention, ultimately optimizing the drug development cycle and giving Conduit a significant competitive advantage.“By incorporating Sarborg’s cutting-edge AI and cybernetics platform, Conduit is taking a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/conduit-pharmaceuticals-revolutionize-drug-development-123000853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDTTW","CDT","BK4121"],"gpt_icon":0},{"id":"2486061158","title":"Conduit Pharmaceuticals files to sell 75M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486061158","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486061158?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:20","pubTimestamp":1732573257,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals (NASDAQ:CDT) filed to sell 75,000,000 shares of common stock for holders.\nFiling","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4332646-conduit-pharmaceuticals-files-to-sell-75m-shares-of-common-stock-for-holders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2485962534","title":"Conduit Pharmaceuticals Receives Japan Patent for Lead Asset AZD1656","url":"https://stock-news.laohu8.com/highlight/detail?id=2485962534","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485962534?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:33","pubTimestamp":1732195990,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals  said Thursday that the Japan Patent Office has approved a composition of matter patent for the company's lead asset, AZD1656, which is a glucokinase activator that targets various autoimmune disorders.The company said the approval follows a recent patent grant in Australia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","CDT.AU","CDT","BK4121","BK7104","XJO.AU","XKO.AU"],"gpt_icon":0},{"id":"2485846010","title":"BRIEF-Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2485846010","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485846010?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:33","pubTimestamp":1732192418,"startTime":"0","endTime":"0","summary":"Nov 21 (Reuters) - Conduit Pharmaceuticals Inc   :   * CONDUIT PHARMACEUTICALS RECEIVES FURTHER PATENT APPROVAL FOR LEAD ASSET TARGETING AUTOIMMUNE DISORDERSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2485973460","title":"Conduit Pharmaceuticals Receives Further Patent Approval for Lead Asset Targeting Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2485973460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485973460?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MS0NO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2484097629","title":"BRIEF-Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2484097629","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484097629?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:58","pubTimestamp":1732053517,"startTime":"0","endTime":"0","summary":"BRIEF-Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of DirectorsNov 19 (Reuters) - Conduit Pharmaceuticals Inc CDT.O:CONDUIT PHARMACEUTICALS ANNOUNCES APPOINTMENT OF SIMON FRY TO BOARD OF DIRECTORSSource text: ID:nGNX3CFQkTFurther company coverage: CDT.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA7MHBKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2484068179","title":"Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2484068179","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484068179?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:30","pubTimestamp":1732051801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA7MHBKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2484042905","title":"Press Release: Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2484042905","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484042905?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:30","pubTimestamp":1732051800,"startTime":"0","endTime":"0","summary":"-- Conduit Pharmaceuticals strengthens its Board of Directors with the. addition of Simon Fry, a seasoned investment banking executive with over. 30 years of experience in asset management, capital markets, and strategy. Mr. Fry was appointed to the Board of Directors for his extensive expertise in capital markets and strategic asset management and will bring valuable insight to Conduit's growth objectives. Mr. Fry's appointment to the Board will be effective on December 18, 2024, at the conclusion of the Company's annual meeting. It is expected Mr. Fry will serve on both the Audit Committee and the Compensation Committee.\"Simon's depth of experience in capital markets and investment strategy brings tremendous value to Conduit as we expand our pipeline and explore new opportunities for growth,\" said Dr. David Tapolczay, Chief Executive Officer of Conduit Pharmaceuticals. \"We are thrilled to welcome Simon to the Board and look forward to leveraging his expertise to enhance our strategic","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2483594983","title":"Conduit Pharmaceuticals: Financial Statement for Qtr Ended Mar 31, 3 & 6 Months Ended June 30 Should Not Be Relied Upon","url":"https://stock-news.laohu8.com/highlight/detail?id=2483594983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483594983?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:38","pubTimestamp":1731623910,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML1NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2481503031","title":"Conduit Pharmaceuticals announces new addition to autoimmune pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2481503031","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481503031?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:40","pubTimestamp":1730810407,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals  announces the filing of two new patent applications relating to its lead clinical candidate, AZD1656, a HK-4 glucokinase activator licensed from AstraZeneca targeting a broad spectrum of autoimmune disorders. The patent applications include a novel composition of matter filing for CDT1656, the newly introduced asset in Conduit’s portfolio. CDT1656 combines AZD1656 with a second compound whose mechanism of action plays a critical role in the progression of autoimmune disorders and has shown potential across a range of conditions. This combination provides an expansion to Conduit’s pipeline, creating an innovative addition to the Company’s autoimmune portfolio. Conduit believes that the development of CDT1656 has the potential to expand the market opportunity for the Company across a broader range of autoimmune conditions and patient subsets further strengthening its strategic position.Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements. Conduit ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/conduit-pharmaceuticals-announces-addition-autoimmune-124007357.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/conduit-pharmaceuticals-announces-addition-autoimmune-124007357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDTTW","CDT","BK4121"],"gpt_icon":0},{"id":"2480886125","title":"BRIEF-Conduit Pharmaceuticals Announces New Addition To Its Autoimmune Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2480886125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480886125?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:23","pubTimestamp":1730726589,"startTime":"0","endTime":"0","summary":"Nov 4  - Conduit Pharmaceuticals Inc   :   * CONDUIT PHARMACEUTICALS ANNOUNCES NEW ADDITION TO ITS AUTOIMMUNE PIPELINE   * CONDUIT PHARMACEUTICALS - PATENT APPLICATIONS INCLUDE NOVEL COMPOSITION OF MATTER FILING FOR CDT1656Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2480302871","title":"Conduit Pharmaceuticals - Patent Applications Include Novel Composition of Matter Filing for CDT1656","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480302871?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:32","pubTimestamp":1730723525,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB0IE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2480302870","title":"Conduit Pharmaceuticals Announces New Addition to Its Autoimmune Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480302870?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:32","pubTimestamp":1730723525,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB0IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2480866974","title":"BRIEF-Conduit Pharmaceuticals announces debt restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2480866974","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480866974?lang=en_us&edition=fundamental","pubTime":"2024-11-02 06:00","pubTimestamp":1730498404,"startTime":"0","endTime":"0","summary":"Nov 1  - Conduit Pharmaceuticals Inc   :   * CONDUIT PHARMACEUTICALS ANNOUNCES DEBT RESTRUCTURING AND ADDITIONAL NOTES   * CONDUIT PHARMACEUTICALS INC - RESTRUCTURES $2.65 MILLION LOAN NOTE WITH NIRLAND, SECURES $1.2 MILLION IN NEW NOTESSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2480850593","title":"Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2480850593","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480850593?lang=en_us&edition=fundamental","pubTime":"2024-11-02 04:45","pubTimestamp":1730493900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241101:nTUA53BPCK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.conduitpharma.com","stockEarnings":[{"period":"1week","weight":-0.2625},{"period":"1month","weight":-0.476},{"period":"3month","weight":-0.5675},{"period":"6month","weight":-0.9486},{"period":"1year","weight":-0.9887},{"period":"ytd","weight":-0.988}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0014},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2555},{"period":"ytd","weight":0.2512}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.","exchange":"NASDAQ","name":"Conduit Pharmaceuticals Inc.","nameEN":"Conduit Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Conduit Pharmaceuticals Inc.(CDT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Conduit Pharmaceuticals Inc.(CDT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Conduit Pharmaceuticals Inc.,CDT,Conduit Pharmaceuticals Inc.股票,Conduit Pharmaceuticals Inc.股票老虎,Conduit Pharmaceuticals Inc.股票老虎国际,Conduit Pharmaceuticals Inc.行情,Conduit Pharmaceuticals Inc.股票行情,Conduit Pharmaceuticals Inc.股价,Conduit Pharmaceuticals Inc.股市,Conduit Pharmaceuticals Inc.股票价格,Conduit Pharmaceuticals Inc.股票交易,Conduit Pharmaceuticals Inc.股票购买,Conduit Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Conduit Pharmaceuticals Inc.(CDT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Conduit Pharmaceuticals Inc.(CDT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}